Enuff Capsule contains Racecadotril 100 mg, an effective antidiarrheal agent used primarily for the symptomatic treatment of acute diarrhea. Racecadotril acts as an enkephalinase inhibitor, reducing the secretion of water and electrolytes into the intestinal lumen without affecting intestinal motility, thereby helping to restore normal bowel function. It is indicated for adults and children over the age of three months experiencing acute diarrhea, including cases associated with infectious gastroenteritis. The capsule formulation allows for convenient oral administration and rapid absorption. Enuff Capsule is generally well tolerated, with a low incidence of adverse effects; common side effects may include mild gastrointestinal discomfort or rash. It is contraindicated in patients with known hypersensitivity to Racecadotril or any component of the formulation. Caution is advised in patients with severe hepatic or renal impairment. Enuff Capsule should be used alongside appropriate rehydration therapy to prevent dehydration and electrolyte imbalance. It is not recommended for chronic diarrhea or diarrhea caused by invasive pathogens requiring antibiotic treatment. Patients should follow the prescribed dosage and consult a healthcare professional if symptoms persist beyond five days or worsen, to ensure appropriate management and rule out underlying conditions.